Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Journal of Korean Medical Science ; : e37-2019.
Artículo en Inglés | WPRIM | ID: wpr-765145

RESUMEN

BACKGROUND: Alendronate (AL), a drug for inhibiting osteoclast-mediated bone-resorption, was intercalated into an inorganic drug delivery nanovehicle, layered double hydroxide (LDH), to form a new nanohybrid, AL-LDH, with 1:1 heterostructure along the crystallographic C-axis. Based on the intercalation reaction strategy, the present AL-LDH drug delivery system (DDS) was realized with an enhanced drug efficacy of AL, which was confirmed by the improved proliferation and osteogenic differentiation of osteoblast-like cells (MG63). METHODS: The AL-LDH nanohybrid was synthesized by conventional ion-exchange reaction and characterized by powder X-ray diffraction (PXRD), high-resolution transmission electron microscopy (HR-TEM), and Fourier transform infrared (FT-IR) spectroscopy. Additionally, in vitro efficacy tests, such as cell proliferation and alkaline phosphatase (ALP) activity, were analyzed. RESULTS: The AL was successfully intercalated into LDH via ion-exchange reaction, and thus prepared AL-LDH DDS was X-ray single phasic and chemically well defined. The accumulated AL content in MG63 cells treated with the AL-LDH DDS nanoparticles was determined to be 10.6-fold higher than that within those treated with the intact AL after incubation for 1 hour, suggesting that intercellular permeation of AL was facilitated thanks to the hybridization with drug delivery vehicle, LDH. Furthermore, both in vitro proliferation level and ALP activity of MG63 treated with the present hybrid drug, AL-LDH, were found to be much more enhanced than those treated with the intact AL. This is surely due to the fact that LDH could deliver AL drug very efficiently, although LDH itself does not show any effect on proliferation and osteogenic differentiation of MG63 cells. CONCLUSION: The present AL-LDH could be considered as a promising DDS for improving efficacy of AL.


Asunto(s)
Alendronato , Fosfatasa Alcalina , Proliferación Celular , Sistemas de Liberación de Medicamentos , Análisis de Fourier , Técnicas In Vitro , Microscopía Electrónica de Transmisión , Nanopartículas , Análisis Espectral , Difracción de Rayos X
2.
Electron. j. biotechnol ; 32: 13-18, Mar. 2018. ilus, graf
Artículo en Inglés | LILACS | ID: biblio-1022495

RESUMEN

Background: The suppression of cancer cell growth and invasion has become a challenging clinical issue. In this study, we used nanotechnology to create a new drug delivery system to enhance the efficacy of existing drugs. We developed layered double hydroxide by combing Au nanosol (LDH@Au) and characterized the compound to prove its function as a drug delivery agent. The anti-cancer drug Doxorubicin was loaded into the new drug carrier to assess its quality. We used a combination of apoptosis assays, cell cycle assays, tissue distribution studies, cell endocytosis, transwell invasion assays, and immunoblotting to evaluate the characteristics of LDH@Au as a drug delivery system. Results: Our results show that the LDH@Au-Dox treatment significantly increased cancer cell apoptosis and inhibited cell invasion compared to the control Dox group. Additionally, our data indicate that LDH@Au-Dox has a better target efficiency at the tumor site and improved the following: cellular uptake, anti-angiogenesis action, changes in the cell cycle, and increased caspase pathway activation. Conclusions: Our findings suggest the nano drug is a promising anti-cancer agent and has potential clinical applications.


Asunto(s)
Neoplasias Gástricas/tratamiento farmacológico , Doxorrubicina/administración & dosificación , Apoptosis/efectos de los fármacos , Nanopartículas/administración & dosificación , Antibióticos Antineoplásicos/administración & dosificación , Doxorrubicina/farmacología , Ciclo Celular/efectos de los fármacos , Western Blotting , Sistemas de Liberación de Medicamentos , Nanotecnología , Línea Celular Tumoral , Microscopía Electrónica de Transmisión , Proliferación Celular/efectos de los fármacos , Endocitosis/efectos de los fármacos , Hidróxidos , Antibióticos Antineoplásicos/farmacología , Invasividad Neoplásica/prevención & control
3.
Journal of Pharmaceutical Analysis ; (6): 331-338, 2014.
Artículo en Chino | WPRIM | ID: wpr-473729

RESUMEN

In this work, the nickel-aluminum layered double hydroxide (Ni-Al LDH) with nitrate interlayer anion was synthesized and used as a solid phase extraction sorbent for the selective separation and pre-concentration of mefenamic acid prior to quantification by UV detection at λmax ? 286 nm. Extraction procedure is based on the adsorption of mefenamate anions on the Ni-Al(NO3? ) LDH and/or their exchange with LDH interlayer NO3? anions. The effects of several parameters such as cations and interlayer anions type in LDH structure, pH, sample flow rate, elution conditions, amount of nano-sorbent and co-existing ions on the extraction were investigated and optimized. Under the optimum conditions, the calibration graph was linear within the range of 2-1000 mg/L with a correlation coefficient of 0.9995. The limit of detection and relative standard deviation were 0.6 mg/L and 0.84% (30 mg/L, n ? 6), respectively. The presented method was successfully applied to determine of mefenamic acid in human serum and pharmaceutical wastewater samples.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA